Crystal structure of (2E)-2-[1-(4-bromophenyl)-3-(1H-imidazol-1-yl) propylidene]-N-(2,4-dichlorophenyl)hydrazinecarboxamide, C19H16BrCl2N5O
C19H16BrCl2N5O, triclinic, P1̅ (no. 2), a = 7.4661(3) Å, b = 10.9874(4) Å, c = 12.8619(5) Å, ɑ = 109.979(3)°, β = 92.053(3)°, γ = 95.677(3)°, V = 984.0 Å3, Z = 2, Rgt(F) = 0.0653, wRref(F2) = 0.1906, T = 296 K.
Main Authors: | Al-Wabli Reem I., Attia Mohamed I., Ghabbour Hazem A., El-Sayed Nahed N. E., Fun Hoong-Kun |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2015-09-01
|
Series: | Zeitschrift für Kristallographie - New Crystal Structures |
Online Access: | https://doi.org/10.1515/ncrs-2014-9078 |
Similar Items
-
Anticonvulsant Potential of Certain New (2E)-2-[1-Aryl-3-(1H-imidazol-1-yl)propylidene]-N-(aryl/H)hydrazinecarboxamides
by: Mohamed I. Attia, et al.
Published: (2014-01-01) -
N-Phenyl-2-(propan-2-ylidene)hydrazinecarboxamide
by: Hoong-Kun Fun, et al.
Published: (2012-03-01) -
Spectroscopic Investigations, DFT Calculations, and Molecular Docking Studies of the Anticonvulsant (2E)-2-[3-(1H-Imidazol-1-yl)-1-phenylpropylidene]-N-(4-methylphenyl)hydrazinecarboxamide
by: Reem I. Al-Wabli, et al.
Published: (2016-01-01) -
Crystal structure of 1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-5-((3-bromophenyl) methyleneimino)-1H-pyrazole-3-carbonitrile, C18H8BrCl2F3N4
by: Zhang X.-G., et al.
Published: (2006-12-01) -
Crystal structure of 1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-5-((3-bromophenyl) methyleneimino)-1H-pyrazole-3-carbonitrile, C18H8BrCl2F3N4
by: Zhang X.-G., et al.
Published: (2006-04-01)